In the scope of the “Visit of delegation led by Chief Executive of Macao SAR and University of Macau Delegation to the University of Lisbon”, Technophage was invited to present the work that has been developed since 2014 in collaboration with the University of Macau.

Professor Simon Lee from the University of Macau presented the context and efficacy data of the C1 bioactive compound, while Miguel Garcia, CEO of Technophage, focused on the manufacturing process, analytical data, toxicology study and regulatory perspective for the development of this novel food ingredient derived from a Chinese plant.

Technophage is planning to continue to develop this molecule as a therapeutic, as well as a novel food, with the pleasant collaboration with the University of Macau.

More information availabe here.